Leadership
Giulio F. Draetta, M.D., Ph.D.
Sr. Vice President and Head, Therapeutics Discovery
Co-Leader, Moon Shots Program™
Professor, Genomic Medicine
Ad-interim Chief Scientific Officer
Philip Jones, Ph.D.
Vice President, Therapeutics Discovery
Head of Drug Discovery, Institute for Applied Cancer Science (IACS)
Platform Leadership
The Therapeutics Discovery division supports four research platforms.
Institute for Applied Cancer Science (IACS)
-
Philip Jones, Ph.D.
Head of Drug Discovery
Oncology Research for Biologics and Immunotherapy Translation (ORBIT)
-
Dongxing Zha, Ph.D.
Associate Director
Neurodegeneration Consortium (NDC)
-
Jim Ray, Ph.D.
Head, Neurodegeneration Research